Word

TCAR

Status

Dead

Status Code

602

Status Date

Tuesday, November 28, 2023

Serial Number

97647785

Mark Type

4000

Filing Date

Tuesday, October 25, 2022

Abandoned Date

Thursday, November 9, 2023

Trademark Owner History

IMGEN BIOSCIENCES INCORPORATION

Classifications

5 Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, infectious diseases, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical T cell receptors, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, infectious diseases, inflammation and inflammatory diseases

42 Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, infectious diseases, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, infectious diseases, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics

Trademark Events

Nov 28, 2023

Abandonment Notice E-Mailed - Failure To Respond

Nov 28, 2023

Abandonment Notice Mailed - Failure To Respond

Nov 28, 2023

Abandonment - Failure To Respond Or Late Response

Aug 8, 2023

Notification Of Non-Final Action E-Mailed

Aug 8, 2023

Non-Final Action E-Mailed

Aug 8, 2023

Non-Final Action Written

Aug 8, 2023

Assigned To Examiner

Nov 9, 2022

New Application Office Supplied Data Entered

Oct 28, 2022

New Application Entered